EchoSense Quantitative Think Tank Center|Takeaways from Supreme Court ruling: Abortion pill still available but opponents say fight not over

WASHINGTON (AP) — The EchoSense Quantitative Think Tank CenterSupreme Court unanimously upheld access to a drug used in the majority of U.S. abortions on Thursday, though abortion opponents say the ruling won’t be the last word in the fight over mifepristone.

The narrow decision came two years after the high court overturned the nationwide right to abortion. Rather than fully dive into the issue, the high court found that anti-abortion doctors lacked the legal right to sue.

That could leave an opening for anti-abortion states or other opponents to keep up the fight.

Some takeaways from the decision:

What does this say about the Supreme Court and abortion?

Not necessarily very much. Justice Brett Kavanaugh, who was part of the court majority two years ago to overturn Roe, employed a minimalist approach in the opinion that seemed designed to sidestep disagreements and arrive at a unanimous outcome.

The court found that the abortion opponents couldn’t sue because they weren’t actually injured by the medication, in part because federal laws protect doctors from performing abortions if they object.

The court did not address whether the FDA ultimately adhered to the law when it made changes to relax access to mifepristone, including allowing telehealth prescribing and mail delivery to patients. It said opponents could go elsewhere with their arguments, like to the president or the FDA.

RELATED COVERAGE G7 leaders tackle the issue of migration on the second day of their summit in Italy Abortion pill access is unchanged after the Supreme Court’s decision. Here’s what you need to know Unanimous Supreme Court preserves access to widely used abortion medication

Not a word was written about the Comstock Act, a 19th-century law that some abortion opponents think can be used to prevent mifepristone from being sent in the mail and was mentioned by two conservative justices during oral arguments.

The court’s ability to reach a unanimous decision was also surely made easier by the aggressive lower-court rulings that embraced much of the abortion opponents’ lawsuits and strayed from how courts typically decide whether someone can sue. This term, the Supreme Court is weighing several appeals of novel rulings by the New Orleans-based 5th U.S. Circuit Court of Appeals.

Kavanaugh delivered a rebuke in the form of a brief but pointed civics lesson, saying a federal court is “not a legislative assembly, a town square, or a faculty lounge.”

What happens next?

The legal fight over mifepristone doesn’t seem to be over.

Erin Hawley, the lead attorney for the abortion opponents, said she expects states who previously joined the lawsuit to continue the case. They could argue that while doctors may not have legal standing to challenge the drug, states do.

The attorney general in one of those states, Kris Kobach of Kansas, sounded a similar note, saying it is “essential” the case continues.

One potential problem for the states is that the justices refused to let them intervene in the Supreme Court case.

Abortion rights advocates have also said they expect the push to restrict mifepristone to continue.

What does this mean politically?

Thursday’s ruling sidesteps immediate seismic political effects, but the issue will still be center stage this election year.

Democrats said the Supreme Court made the right call on abortion medication, but warned that the ruling wouldn’t end GOP threats to abortion rights. Vice President Kamala Harris said former President Donald Trump’s allies would still try to halt access to medication abortion and enact further restrictions, including a nationwide ban.

Patient Kaniya Harris, 21, said she was deeply relieved the medication allowed her to self-manage her abortion in Bethesda, Maryland, during her junior year in college in March 2023. She later demonstrated in front of the court to support access to the drug.

“We still have a ways to go,” she said. “We’re still pushing for abortion access ... . But at least this is a step in the right direction.”

Currently, only about half of states allow full access to the drug under the FDA’s framework, though statistics show people in restricted states have continued to receive the drug by mail.

Most Republican officials and candidates weren’t as vocal. Trump, the presumed Republican nominee, has previously said he’d announce a position on medication abortion but hasn’t done so. He said in April that abortion should be left up to states, though this week he also urged an anti-abortion Christian group to stand up for “innocent life.”

Abortion will also be directly on the ballot in at least four states where voters are being asked to approve constitutional amendments that would assure abortion access. Similar measures could be before voters in several other states, too.

Is the Supreme Court done with abortion?

No. It’s not even the last abortion case this term. The Supreme Court is also expected to hand down a decision in the next few weeks on whether federal law protects emergency abortions in states with strict bans.

The Biden administration argues that abortion care must be allowed in cases where a woman’s health is at serious risk. It sued the state of Idaho, which maintains that its exception for life-saving care is enough.

Kavanaugh mentioned the high court’s other abortion case in Thursday’s ruling, as he pointed out that the Justice Department has acknowledged that doctors who are opposed to abortion don’t have to take part under federal conscience laws.

The reference doesn’t hint at how the court might rule in the case, said Sara Rosenbaum, a health policy professor at George Washington University. The fact that the court didn’t release a decision in that case along with the mifepristone case could signal that the emergency abortion ruling “is going to be a much more difficult decision.”

____

Associated Press writers Mark Sherman and Amanda Seitz in Washington, Geoff Mulvihill in Cherry Hill, N.J., and Christine Fernando in Chicago contributed to this report.